Morgan, C. L., Durand, A. ., McCormack, T. ., Hughes, E. ., Berni, T. R., & Lahoz, R. . (2023). Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the CPRD. BMJ Open, 13, e064541. http://doi.org/10.1136/bmjopen-2022-064541
Cholesterol, LDL
Weldegiorgis, M. ., & Woodward, M. . (2022). Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom. BMC Nephrol, 23, 312. http://doi.org/10.1186/s12882-022-02932-2
Danese, M. ., Sidelnikov, E. ., Villa, G. ., Catterick, D. ., Iqbal, M. ., Gleeson, M. ., … Patel, J. . (2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. BMJ Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015